Clinical research

Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry

EuroIntervention 2013;9:484-492. DOI: 10.4244/EIJV9I4A78

Michael Böhm
Michael Böhm1*, MD; Felix Mahfoud1, MD; Christian Ukena1, MD; Axel Bauer2, MD; Eckart Fleck3, MD; Uta C. Hoppe4, MD; Ulrich Kintscher5, MD; Krzysztof Narkiewicz6, MD, PhD; Manuela Negoita7, MD; Luis Ruilope8, MD, PhD; L. Christian Rump9, MD; Markus Schlaich10, MD; Roland Schmieder11, MD; Horst Sievert12, MD; Joachim Weil13, MD; Bryan Williams14, MD; Uwe Zeymer15, MD; Giuseppe Mancia16, MD, PhD
1. Universitätskliniken des Saarlandes, Klinik für Innere Medizin III, Homburg/Saar, Germany; 2. Universitätsklinikum Tübingen, Innere Medizin III, Tübingen, Germany; 3. Deutsches Herzzentrum Berlin, Klinik für Innere Medizin – Kardiolo

Aims: Hypertension is a global healthcare concern associated with a wide range of comorbidities. The recognition that elevated sympathetic drive plays an important role in the pathogenesis of hypertension led to the use of re

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

cardiovascular interventionshypertensionrenal denervationresistant hypertensionsympathetic nervous system
Read next article
First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels - results from the meriT-1 trial

Latest news